ATE100323T1 - Verbesserungen betreffend die verabreichung pharmazeutischer mittel. - Google Patents

Verbesserungen betreffend die verabreichung pharmazeutischer mittel.

Info

Publication number: ATE100323T1
Authority: AT; Austria
Prior art keywords: administration; pharmaceutical agents; flavonoid; bioavailability; improvements concerning
Prior art date: 1989-11-28

Application number

AT90312943T

Other languages

English (en)

Inventor

David G Bailey

Bo Edgar

Original Assignee

David G Bailey

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-11-28

Filing date

1990-11-28

Publication date

1994-02-15

1990-11-28 Application filed by David G Bailey filed Critical David G Bailey

1994-02-15 Application granted granted Critical

1994-02-15 Publication of ATE100323T1 publication Critical patent/ATE100323T1/de

Links

239000008177 pharmaceutical agent Substances 0.000 title abstract 4
229930003935 flavonoid Natural products 0.000 abstract 2
150000002215 flavonoids Chemical class 0.000 abstract 2
235000017173 flavonoids Nutrition 0.000 abstract 2
TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 abstract 1
PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 abstract 1
102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 abstract 1
108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 abstract 1
230000003276 anti-hypertensive effect Effects 0.000 abstract 1
125000004925 dihydropyridyl group Chemical group N1(CC=CC=C1)* 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
125000003563 glycoside group Chemical group 0.000 abstract 1
235000015201 grapefruit juice Nutrition 0.000 abstract 1
PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 abstract 1
HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 abstract 1
229960001597 nifedipine Drugs 0.000 abstract 1
230000003647 oxidation Effects 0.000 abstract 1
238000007254 oxidation reaction Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Oil, Petroleum & Natural Gas (AREA)
Biochemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Hydrogenated Pyridines (AREA)

AT90312943T 1989-11-28 1990-11-28 Verbesserungen betreffend die verabreichung pharmazeutischer mittel. ATE100323T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB898926715A GB8926715D0 (en)	1989-11-28	1989-11-28	Improvements relating to the administration of pharmaceutical agents
EP90312943A EP0431828B1 (de)	1989-11-28	1990-11-28	Verbesserungen betreffend die Verabreichung pharmazeutischer Mittel

Publications (1)

Publication Number	Publication Date
ATE100323T1 true ATE100323T1 (de)	1994-02-15

Family

ID=10666948

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT90312943T ATE100323T1 (de)	1989-11-28	1990-11-28	Verbesserungen betreffend die verabreichung pharmazeutischer mittel.

Country Status (6)

Country	Link
US (1)	US5229116A (de)
EP (1)	EP0431828B1 (de)
AT (1)	ATE100323T1 (de)
CA (1)	CA2030962C (de)
DE (1)	DE69006202T2 (de)
GB (1)	GB8926715D0 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7624028B1 (en)	1992-11-17	2009-11-24	Health Hero Network, Inc.	Remote health monitoring and maintenance system
WO2001037174A1 (en)	1992-11-17	2001-05-25	Health Hero Network, Inc.	Method and system for improving adherence with a diet program or other medical regimen
US20010011224A1 (en)	1995-06-07	2001-08-02	Stephen James Brown	Modular microprocessor-based health monitoring system
US5307263A (en)	1992-11-17	1994-04-26	Raya Systems, Inc.	Modular microprocessor-based health monitoring system
US9215979B2 (en) *	1992-11-17	2015-12-22	Robert Bosch Healthcare Systems, Inc.	Multi-user remote health monitoring system
US6968375B1 (en)	1997-03-28	2005-11-22	Health Hero Network, Inc.	Networked system for interactive communication and remote monitoring of individuals
JPH0725761A (ja) *	1993-07-09	1995-01-27	Kureha Chem Ind Co Ltd	軟骨保護剤
US6245805B1 (en)	1995-10-26	2001-06-12	Baker Norton Pharmaceuticals, Inc.	Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
US6124477A (en) *	1996-06-27	2000-09-26	Bioavailability Systems, Llc	Anti-first-pass effect compounds
US5820915A (en) *	1996-06-27	1998-10-13	Bioavailability Systems, L.L.C.	Method for the preparation of a first-pass effective citrus-derived substance and product thereof
US6063809A (en) *	1997-08-26	2000-05-16	Bioavailability Systems, Llc	Anti-first-pass effect compounds
US6248776B1 (en)	1997-08-26	2001-06-19	Bioavailability Systems, L.L.C.	Anti-first-pass effect compounds
WO2001031546A2 (en) *	1999-10-28	2001-05-03	Supersale.Com	Method and apparatus for acquiring and providing inventory data
US7169763B2 (en) *	2002-02-22	2007-01-30	Oliver Yoa-Pu Hu	Cytochrome P450 3A inhibitors and enhancers
US20060014677A1 (en) *	2004-07-19	2006-01-19	Isotechnika International Inc.	Method for maximizing efficacy and predicting and minimizing toxicity of calcineurin inhibitor compounds
CA2587406A1 (en) *	2004-11-16	2006-05-26	Limerick Neurosciences, Inc.	Methods and compositions for treating pain
US8017649B2 (en) *	2005-03-11	2011-09-13	Howard Florey Institute Of Experimental Physiology And Medicine	Flavonoid compounds and uses thereof
WO2016134363A1 (en) *	2015-02-20	2016-08-25	Sethi Paul M	Compositions comprising benzoyl peroxide or a derivative thereof and at least one antiseptic skin preparation agent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE586723A (fr) *	1960-01-19	1960-07-19	Sarec S A	Nouveaux composes chimiques et thérapeutiques dérives des isoflavones, et leurs procédés de préparation.
CH444861A (de) *	1963-12-20	1967-10-15	Hoffmann La Roche	Antioxydativ wirksames Mittel
DE3419131A1 (de) *	1984-05-23	1985-11-28	Bayer Ag, 5090 Leverkusen	Dihydropyridinkombinationspraeparate und verfahren zu ihrer herstellung
FR2568773B1 (fr) *	1984-08-10	1989-03-03	Sandoz Lab	Nouvelles compositions pharmaceutiques administrables par voie nasale
CH662505A5 (it) *	1985-04-30	1987-10-15	Seuref Ag	Composizioni farmaceutiche ad azione protettiva vascolare.

1989
- 1989-11-28 GB GB898926715A patent/GB8926715D0/en active Pending
1990
- 1990-11-27 CA CA002030962A patent/CA2030962C/en not_active Expired - Fee Related
- 1990-11-28 US US07/659,495 patent/US5229116A/en not_active Expired - Fee Related
- 1990-11-28 AT AT90312943T patent/ATE100323T1/de not_active IP Right Cessation
- 1990-11-28 DE DE90312943T patent/DE69006202T2/de not_active Expired - Fee Related
- 1990-11-28 EP EP90312943A patent/EP0431828B1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CA2030962C (en)	2003-01-28
US5229116A (en)	1993-07-20
EP0431828B1 (de)	1994-01-19
EP0431828A1 (de)	1991-06-12
CA2030962A1 (en)	1991-05-29
DE69006202T2 (de)	1994-05-05
DE69006202D1 (de)	1994-03-03
GB8926715D0 (en)	1990-01-17

Similar Documents

Publication	Publication Date	Title
ATE100323T1 (de)	1994-02-15	Verbesserungen betreffend die verabreichung pharmazeutischer mittel.
TW355683B (en)	1999-04-11	Composition containing micronized nebivolol
DE3854148D1 (de)	1995-08-17	Fluorcytidinderivate, deren Herstellung und Arzneimittel, die diese Derivate enthalten.
ATE247953T1 (de)	2003-09-15	Arzneimittel mit verzögerter wirkstoffabgabe enthaltend isoquercetin und ascorbinsäure
EP1283054A4 (de)	2006-04-12	Medikamente zur behandlung von komplikationen des diabetes und neuropathien, und verwendung davon
ATE232090T1 (de)	2003-02-15	Orale pharmazeutische zusammensetzungen die pantoprazol mit verzögerter freisetzung und antimikrobielle mittel enthalten
ATE186212T1 (de)	1999-11-15	Geschmacksmaskierte pharmazeutische mittel
EP0214647A3 (en)	1987-09-30	Inclusion complexes of 7-isopropoxy-isoflavone and cyclodextrins, process for their preparation and pharmaceutical preparations containing these complexes
IS3644A7 (is)	1991-05-23	Aðferð til að framleiða lyfjablöndu á formi smápilla til að meðhöndla þarmabólgur
FR2708606B1 (fr)	1995-10-27	Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant.
HUT55403A (en)	1991-05-28	Process for producing modified gangliosides and their functional derivatives, as well as pharmaceutical compositions comprising such active ingredient
HUT70150A (en)	1995-09-28	Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines, pharmaceutical compositions containing them and method for its preparation
FR2697841B1 (fr)	1995-01-13	Nouveaux dérivés du taxane, leur préparation et les compositions pharmaceutiques qui les contiennent.
ES2115616T3 (es)	1998-07-01	Utilizacion de inositoltrisfosfato en la preparacion de medicamentos.
FR2697019B1 (fr)	1994-11-25	Nouveaux dérivés du taxane, leur préparation et les compositions pharmaceutiques qui les contiennent.
KR910005858A (ko)	1991-04-27	지방산 요법
IL88971A0 (en)	1989-08-15	Disubstituted pyridines,their preparation and pharmaceutical compositions containing them
DK0437294T3 (da)	1994-03-07	Orale farmaceutiske præparater i enhedsdosisform
DE3788195D1 (de)	1993-12-23	DIBENZ[b,e]OXEPINDERIVATE, SOWIE ARZNEIMITTEL, DIE DIESE ALS AKTIVE MITTEL ENTHALTEN.
HUT49598A (en)	1989-10-30	Process for producing chromone derivatives and pharmaceutical compositions comprising same as active ingredient
CA2078869A1 (en)	1991-09-24	Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use
IL102032A0 (en)	1992-12-30	2-amino-5-cyano-1,4-dihydropyridines,their preparation and pharmaceutical compositions containing them
CA2361081A1 (en)	2000-07-27	Chaperonin 10 and .beta.-interferon therapy of multiple sclerosis
ATE173624T1 (de)	1998-12-15	Synergistische pharmazeutische zusammensetungen, die triamcinolonacetonid und halcinonid enthalten
IT1204400B (it)	1989-03-01	Composizioni farmaceutiche contenente una calcitonina

Legal Events

Date	Code	Title	Description
1994-07-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties